Louisiana Administrative Code › Title 46 - PROFESSIONAL AND OCCUPATIONAL STANDARDS › Part XLV - Medical Professions › Subpart 3 - Practice › Chapter 69 - Prescription, Dispensation, and Administration of Medications › Subchapter B - Medications Used in the Treatment of Non-Cancer-Related Chronic or Intractable Pain › Section XLV-6917 - Definitions

Current through Register Vol. 50, No. 6, June 20, 2024
A. As used in this
					 Subchapter, unless the content clearly states otherwise, the following terms
					 and phrases shall have the meanings specified.
Board
- the Louisiana State Board of
						Medical Examiners.
Chronic Pain
- pain which persists beyond
						the usual course of a disease, beyond the expected time for healing from bodily
						trauma, or pain associated with a long term-incurable or intractable medical
						illness or disease.
Controlled Substance
- any substance
						defined, enumerated or included in federal or state statute or regulations  21
						C.F.R. §1308 . 11-15 or
						R.S.
						40:964, or any substance which may hereafter
						be designated as a controlled substance by amendment or supplementation of such
						regulations and statute.
Diversion
- the conveyance of a
						controlled substance to a person other than the person to whom the drug was
						prescribed or dispensed by a physician.
Intractable Pain
- a chronic pain state
						in which the cause of the pain cannot be eliminated or successfully treated
						without the use of controlled substance therapy and, which in the generally
						accepted course of medical practice, no cure of the cause of pain is possible
						or no cure has been achieved after reasonable efforts have been attempted and
						documented in the patient's medical record.
Noncancer-Related Pain
- that pain which
						is not directly related to symptomatic cancer.
Physical Dependence
- the physiological
						state of neuroadaptation to controlled substance which is characterized by the
						emergence of a withdrawal syndrome if the controlled substance use is stopped
						or decreased abruptly, or if an antagonist is administered. Withdrawal may be
						relieved by readministration of the controlled substance.
Physician
- physicians and surgeons
						licensed by the Board.
Protracted Basis
- utilization of any
						controlled substance for the treatment of noncancer-related chronic or
						intractable pain for a period in excess of 12 weeks during any 12-month
						period.
Substance Abuse
(may also be referred to
						by the term
Addiction
)-a compulsive disorder in which an
						individual becomes preoccupied with obtaining and using a substance, despite
						adverse social, psychological, and/or physical consequences, the continued use
						of which results in a decreased quality of life. The development of controlled
						substance tolerance or physical dependence does not equate with substance abuse
						or addiction.
Tolerance
- refers to the physiologic
						state resulting from regular use of a drug in which an increased dosage is
						needed to produce the same effect or a reduced effect is observed with a
						constant dose. Controlled substance tolerance refers to the need to increase
						the dose of the drug to achieve the same level of analgesia. Controlled
						substance tolerance may or may not be evident during controlled substance
						treatment.
AUTHORITY NOTE:
						Promulgated in accordance with
						R.S.
						37:1270(A)(1), 1270(B)(6)
						and 1285(B).